【テロップ】
※各テロップ文字をクリックすると該当の場所がピンポイントで閲覧できます。
※各テロップ文字をクリックすると該当の場所がピンポイントで閲覧できます。
- 00:54:26.3 Thank you. On HCB, I recently used your BPM to measure my own blood pressure. On finding it was very high, I chose to seek surgical treatment, so thank you for contributing to my own personal wellbeing. For something like blood pressure, there is no question about what constitutes high or low blood pressure. However, for ECG, you need to be a physician to read the data properly. In future, when you commercialize devices that combine a BPM and ECG, will it be possible to use AI to give the general public the ability to read ECG data properly, or will ECG data continue to be something that must be read by a physician? With regard to Zero Events, I believe it may be possible to collaborate with life insurance companies, with discounts on premiums being offered for patients enrolled in Zero Event programs. Is this something you might consider as a business opportunity? My second question is about the automotive business but would you prefer to respond to the first question before moving on?
- 00:55:32.0 Yes, please let us respond to your first question now. (Ogino) In the US, with AliveCor, you are able to get an immediate reading of the ECG data once it has been transmitted. AliveCor uses computer analytics to provide a solid reading. If you pay an additional fee, you will be able to speak with a doctor regarding your readings. In the US, the FDA has already approved an ECG service where you can get a computer generated analysis of your ECG data immediately. Therefore, although it would need to go through the Pharmaceutical Affairs Law approvals process, we could see this type of service become available in Japan in future. Technologically, it is already possible, so for Japan, it would be a matter of securing regulatory approval. On B-to-B opportunities such as collaborations with life insurers and others for the services or systems we envision, we are interested in opportunities in B-to-B with corporates, as touched upon earlier, or with life insurance companies, rather than B-to-C.
- 00:56:39.9 Currently, the US service is based on the patient sending the data to AliveCor. Do you think it might become possible to program a chip in the device that would make it possible to do the analytics at the edge rather than sending data to a central location? Or would it be more difficult to secure approval in Japan if you were to attempt to do this? The current model assumes the data will be sent to a data processing center for analysis. I would think the ability to do the analysis at the edge would make things much more convenient. Do you think it might be challenging to make this work?
- 00:57:09.1 (Ogino) Technologically, I think it should be possible in the near future, and in fact, probably there are parts of the process that can already be done. The question would be getting approvals under the Pharmaceutical Affairs Law and ensuring such a device or service does not infringe the Medical Practitioners’ Act. It is my understanding that it would not be immediately possible to set up a service that uses edge analytics under the current laws in Japan.
- 00:57:24.7 My second question is with regard to the ￥0.5 billion downward revision to the full-year operating income forecasts for AEC. It is a very small adjustment so I would like to know more about the background to the revision. I would like to know whether the adjustment is a reflection of weaker sales in the auto market or if it is because you are making advance investments.
- 00:57:51.0 Basically, although it is a small amount, we are making advance investments in AEC. We are conducting various development projects, related to EVs , autonomous driving and driver monitoring, as well as the development of integrated modules for body control. The scale and number of individual projects and the necessary software development required for such projects has increased. In order to properly support these initiatives, we took the decision to increase our investments relative to our initial plans and factored this into our full-year plan. It is only a small amount, but we felt it is better to communicate properly about our change in plans. It is not the case that we have seen changes in the market that are depressing the topline.
- 00:58:51.4 Understood. Thank you.
- 00:58:53.5 The next question will be our last. Please pass the mic to the person in the front.
【ノート】